A Pharmaco-epidemiological Study of Short Patients Born Small for Gestational Age (SGA), Treated With Saizen® (Recombinant Somatropin)

NCT01082354 · clinicaltrials.gov ↗

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Infant, Small for Gestational Age

Interventions

DRUG: recombinant somatropin

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators

[object Object]